Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medicago Inc MDCGF

GREY:MDCGF - Post Discussion

Medicago Inc > no comment on result ?
View:
Post by victor16 on Feb 02, 2011 3:33pm

no comment on result ?

ok:medicago,baxter,sanofi NO ADJUVANT RESULT
MDG : at the 20 microgram dosage level, 82% of immunized subjects developed an immune response against the H5N1 virus after the second immunization, 65% of subjects had a four-fold increase in HI titers from baseline and 65% of subjects had seroprotective antibody titers.

BAXTER :Regarding seroconversion (development of antibodies) or the percent of subjects demonstrating a more than four-fold increase in titer after immunization, the highest responses were again seen with the 7.5 g and 15 g non-adjuvanted formulations, with 69.0 percent and 68.3 percent seroconversion respectively
https://www.emaxhealth.com/39/23009.html
SANOFI : the company cites a previous study of Sanofi Pasteur's stockpiled H5N1 pandemic influenza vaccine with no adjuvant that revealed that target levels of antibodies were achieved in less than half the subjects even after two 90mcg doses - six times the normal 15mcg dose that provides 75 - 90 per cent protection against seasonal influenza
CONVERT G = MCG
https://www.convertunits.com/from/MCG/to/g
world class result
Comment by fairchij on Feb 02, 2011 5:56pm
Yes the results are consistent with phase 1 or slightly better which from memory was better than the peer group and much better than the old technologgy. I am looking for the buy recomendations which were published after phase 1 but they were on my old computer which had to be put down. If anyone has a copy of the old documents please post a link. Thanks
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities